Also, CD8+ tumor-infiltrating lymphocytes have been shown to correlate with tumor response after chemotherapy in breast cancer patients and chemo-radiotherapy in rectal cancer patients [19, 51, 52]. This evidence concerns the gene CD8A and neoplasm.